High-Risk Weight Loss Increases Death Risk in Obese Patients With CKD
Trajectories of key clinical variables associated with weight loss distinguished patients with physiologic resilience vs vulnerability.
Diagnosis & Disease Information
Semaglutide Beneficial in Obese Patients With HFpEF
Treatment with the glucagon-like-peptide-1 receptor agonist yielded substantial benefits in patients with heart failure with preserved ejection fraction.
Bariatric Surgery Linked to Lower All-Cancer Incidence Among Females
Significant reduction also seen in obesity-related cancer incidence and in cancer mortality after bariatric surgery
Multiple Factors Contribute to Testosterone Decline in Men
Mean testosterone concentration was relatively stable until age 70 years, investigators reported.
Amid Shortages, Maker Says Restrictions on Wegovy Will Continue Into 2024
Based on body mass index, 120 million Americans would qualify to take Wegovy
Hyperfiltration, Kidney Function Decline Tied to Metabolic Syndrome
In a Norwegian study of the general population, individuals with metabolic syndrome were more likely to have renal hyperfiltration and experience steeper long-term declines in glomerular filtration rate.
Wegovy Lowered Users’ Heart Risks in New Trial
Clinical trial demonstrates reduction in major adverse cardiovascular events of 20 percent, drug maker says
Obesity, Diabetes Up Surgical Infection Risk After Radical Cystectomy
Investigators report findings from a retrospective study of 13,081 patients undergoing radical cystectomy.
An Updated Approach to Managing Obesity in Patients With CKD
A recent literature review supports the idea that obesity needs to have an individualized, root cause approach.
Ticagrelor-Acetylsalicylic Acid More Beneficial for Obese With Minor Stroke, TIA
Significantly lower rate of stroke within 90 days seen for ticagrelor-ASA versus clopidogrel-ASA for those carrying CYP2C19 loss-of-function allele.
- Loading...
Loading...
Next post in Cardiovascular Disease (CVD)
Loading... 
Loading...